Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, December 21, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
Aptyx Expands With New Precision Extrusion Center of Excellence in Boston Medtech Corridor
Life Sciences Times
-
December 5, 2025
0
Pharma
Amylyx Pharmaceuticals Reports New Cohort 1 Safety Data for AMX0114 in ALS from First-in-Human LUMINA Trial
Life Sciences Times
-
December 5, 2025
0
Real Estate
Curium Pharma Selects Boston Seaport for New Global Headquarters
Life Sciences Times
-
December 4, 2025
0
Venture Capital
Sempresto Acquires Alerje Autoinjector Platform to Advance Smartphone-Integrated Rescue Medications
Life Sciences Times
-
December 4, 2025
0
People on the Move
Zelis Appoints Jim Bridges as President of Price Optimization
Life Sciences Times
-
December 4, 2025
0
Biotech
Sunbird Bio Reports New Clinical Data Showing Accuracy of Blood-Based Alpha-Synuclein Assay for Parkinson’s Detection
Life Sciences Times
-
December 4, 2025
0
Medtech
Insulet Announces FDA Clearance for Major Omnipod 5 Algorithm Upgrades
Life Sciences Times
-
December 4, 2025
0
People on the Move
beBright Appoints Jeff Komoroski as Chief Financial Officer to Support Strategic Growth
Life Sciences Times
-
December 3, 2025
0
People on the Move
Curebound Appoints Robin Toft as Chief Executive Officer
Life Sciences Times
-
December 3, 2025
0
Technology
Terray Therapeutics Reaches AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
Life Sciences Times
-
December 3, 2025
0
1
...
7
8
9
...
773
Page 8 of 773
Most Popular
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025
Load more
Recent Comments
Recent Comments